Join the club for FREE to access the whole archive and other member benefits.

clock.bio

Longevity biotech company

Clock.bio is dedicated to extending and enhancing the quality of life by reversing the detrimental effects of ageing at the cellular level. By harnessing the regenerative capabilities of human induced pluripotent stem cells (hiPSCs), the company aims to increase human healthspan through innovative treatments that prevent and address age-related diseases. Clock.bio decodes the rejuvenation programs present in these cells, discovering that hiPSCs not only maintain youthfulness but can also rejuvenate when subjected to ageing processes. By leveraging this unique ability to "reset the clock," Clock.bio seeks to develop new strategies for combating the challenges of ageing.

Visit website: https://clock.bio/

 clock-bio

 clockbioltd

See also: Academia University of Cambridge - Collegiate research university in Cambridge, United Kingdom

Details last updated 11-Oct-2024

clock.bio is also referenced in the following:

Stem cells, lab-grown meat, and potential new medical treatments, with Mark Kotter

Mark Kotter discusses stem cells, cultivated meat, and emerging medical treatments

People at clock.bio

Markus Gstöttner

CEO of Clock.bio

clock.bio News

Unlocking the secrets of cellular rejuvenation: Clock.bio’s groundbreaking genetic discoveries

Unlocking the secrets of cellular rejuvenation: Clock.bio’s groundbreaking genetic discoveries

Longevity Technology - 09-Oct-2024

Clock.bio secures funding to explore genetic pathways for enhancing healthspan

Clock.bio: New biotech startup aims to extend human healthspan by 20 years

Clock.bio: New biotech startup aims to extend human healthspan by 20 years

Endpoints News - 31-Aug-2024

Revolutionary approach to reverse ageing process with CRISPR gene editing technology